Arcoma AB Market Cap ($13.21 Million)
Market Cap & Net Worth: Arcoma AB (ARCOMA)
Arcoma AB market cap. Arcoma AB (ST:ARCOMA) has a market capitalization of $13.21 Million (Skr122.77 Million) as of November 5, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #26198 globally and #541 in its home market, demonstrating a 8.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arcoma AB's stock price Skr8.58 by its total outstanding shares 14308510 (14.31 Million). Also see Arcoma AB (ARCOMA) cash flow conversion for how efficiently the company converts equity into cash flow.
Arcoma AB Market Cap History (2015–2026)
Arcoma AB market cap history from 2015 to 2026. Data shows growth from $12.16 Million to $13.21 Million (1.93% CAGR). Check today's stock price for Arcoma AB for real-time trading data and today's change.
Index Memberships
Arcoma AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.29 Billion | 0.09% | #134 of 281 |
Weight: Arcoma AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Arcoma AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arcoma AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Arcoma AB equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.09x
Arcoma AB's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.25x
Arcoma AB's market cap is 2.25 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.81 Million | $102.08 Million | -$11.65 Million | 0.06x | N/A |
| 2017 | $11.55 Million | $91.85 Million | -$9.82 Million | 0.13x | N/A |
| 2018 | $21.02 Million | $119.47 Million | -$1.59 Million | 0.18x | N/A |
| 2019 | $30.49 Million | $133.67 Million | $6.61 Million | 0.23x | 4.61x |
| 2020 | $33.88 Million | $117.42 Million | $1.36 Million | 0.29x | 24.82x |
| 2021 | $20.02 Million | $117.13 Million | -$7.47 Million | 0.17x | N/A |
| 2022 | $11.83 Million | $125.05 Million | $1.90 Million | 0.09x | 6.22x |
| 2023 | $12.24 Million | $163.01 Million | $2.56 Million | 0.08x | 4.77x |
| 2024 | $16.55 Million | $156.81 Million | $11.18 Million | 0.11x | 1.48x |
| 2025 | $11.30 Million | $130.80 Million | $5.03 Million | 0.09x | 2.25x |
Competitor Companies of ARCOMA by Market Capitalization
Companies near Arcoma AB in the global market cap rankings as of November 5, 2026. Also see total assets of Arcoma AB for a full breakdown of the balance sheet.
Key companies related to Arcoma AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Arcoma AB (2015–2026)
Market capitalization of Arcoma AB from 2015 to today. Between 2015 and today, Arcoma AB's market cap moved from $12.16 Million to $ 13.21 Million, with a yearly change of 1.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr13.21 Million | +16.89% |
| 2025 | Skr11.30 Million | -31.72% |
| 2024 | Skr16.55 Million | +35.22% |
| 2023 | Skr12.24 Million | +3.52% |
| 2022 | Skr11.83 Million | -40.92% |
| 2021 | Skr20.02 Million | -40.91% |
| 2020 | Skr33.88 Million | +11.11% |
| 2019 | Skr30.49 Million | +45.05% |
| 2018 | Skr21.02 Million | +82.00% |
| 2017 | Skr11.55 Million | +98.94% |
| 2016 | Skr5.81 Million | -52.28% |
| 2015 | Skr12.16 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Arcoma AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.21 Million USD |
| MoneyControl | $13.21 Million USD |
| MarketWatch | $13.21 Million USD |
| marketcap.company | $13.21 Million USD |
| Reuters | $13.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more